Shuki Gleitman

Dr Shuki Gleitman is chair of the Guangzhuo Israel Biotech Fund, chair of Capital Point Group, board member and chair of the audit and financial committees of Elbit Systems (NASDAQ, TLV traded), chair of YoYa Group, senior advisor to the World Bank (national policy for innovation) and senior strategy advisor to Serbia Innovation Fund. Prior to holding all those positions, Dr Gleitman was the chief scientist and director general of Israel’s Ministry of Industry and Trade, where he managed all of the Israeli Government technological programs. In the course of his four-year tenure, Dr Gleitman was responsible for allocating over $1.5 billion of grants in the framework of promoting research and development activities in the Israeli hightech industry. Dr Gleitman was also chief executive of Ampal Investment Group (NASDAQ: AMPL) where he was responsible for the investment of over $200 million in hightech ventures, and he led a $330 million joint venture with Motorola Israel founding Mirs Communications, Israel’s fourth largest cellular operator. Dr Gleitman holds a PhD (with distinction), MSc (with distinction) and BSc in Physical Chemistry from the Hebrew University of Jerusalem.
Bio last updated 18 Jun 2017

Access to our data for Shuki Gleitman is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Shuki Gleitman is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
thG Medical Innovations Holdings0%0%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Non-Executive Director
Year started and most recent title


th-G Medical Innovations Holdings$140k
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer